Cargando…
The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance
Infectious pandemics result in hundreds and millions of deaths, notable examples of the Spanish Flu, the Black Death and smallpox. The current pandemic, caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), is unprecedented even in the historical term of pandemics. The unprecedente...
Autores principales: | Yan, Daisy, Ra, One Hyuk, Yan, Bingfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422062/ https://www.ncbi.nlm.nih.gov/pubmed/34778881 http://dx.doi.org/10.1186/s44149-021-00017-5 |
Ejemplares similares
-
Advances in antiviral nucleoside analogues and their prodrugs
por: Seley-Radtke, Katherine, et al.
Publicado: (2018) -
In vitro evaluation of the impact of Covid-19 therapeutic agents on the hydrolysis of the antiviral prodrug remdesivir
por: Zhang, Qingchen, et al.
Publicado: (2022) -
Lipophilic prodrugs of nucleoside triphosphates as biochemical probes and potential antivirals
por: Gollnest, Tristan, et al.
Publicado: (2015) -
Rethinking Remdesivir: Synthesis, Antiviral Activity and Pharmacokinetics of Oral Lipid Prodrugs
por: Schooley, Robert T., et al.
Publicado: (2021) -
Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs
por: Schooley, Robert T., et al.
Publicado: (2021)